Epunamin Combined With DECP for Relapsed/Refractory Multiple Myeloma

Clinical trial NCT07497165 · RECRUITING

Trial details

NCT number: NCT07497165
Sponsor: Shanxi Bethune Hospital
Status: RECRUITING
Study type: OBSERVATIONAL

Relapsed/Refractory Multiple Myeloma (RRMM)Multiple Myeloma

Start date: 2025-11-01
Primary completion: 2026-11-30
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.